Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Medical Technology Assessment And Medical Information Technology In Japan PDF full book. Access full book title Medical Technology Assessment And Medical Information Technology In Japan.
| Author | : Akinori Hisashige |
| Publisher | : |
| Total Pages | : 11 |
| Release | : 1991 |
| Genre | : |
| ISBN | : |
| Author | : Isao Kamae |
| Publisher | : Springer Nature |
| Total Pages | : 265 |
| Release | : 2019-09-03 |
| Genre | : Business & Economics |
| ISBN | : 9811357935 |
Representing the first book on the topic, this work offers the reader an introduction to the Japanese systems for health technology assessment (HTA) officially introduced by the Ministry of Health, Labour and Welfare (MHLW) in 2016. Policy and guidelines are discussed, with the relevant methods and conditions of cost-effectiveness analysis explained alongside. Numerous instructive examples and exercises, ranging from basic to advanced, impart valuable knowledge and insight on the quantitative methods for economic evaluation, which will appeal to both beginners and experts. This guidebook is authored by Japan’s foremost expert in HTA and pharmacoeconomics, with a view to strengthening the reader’s expertise in value-based healthcare and decision-making. The methods presented are essential to informing regulatory, local and patient decisions; as such, the book is equally recommended to industry and government, as well as academia, and anyone with an interest in Japanese HTA.
| Author | : Christa Altenstetter |
| Publisher | : Transaction Publishers |
| Total Pages | : 127 |
| Release | : 2014-08-31 |
| Genre | : Medical |
| ISBN | : 141285511X |
Japan is suffering from a “device gap.” Compared to its American and European counterparts, Japan lags in adopting innovative medical devices and making new treatments and procedures available to its patients. Many blame its government and bureaucracy for Japan’s delayed access to modern medicine and new medical devices. Christa Altenstetter examines the contextual social, historical, and political conditions of Japan’s medical field to make sense of the state of the country’s medical profession and its regulatory framework. She explores the development of regulatory frameworks and considers possibilities for eventual reform and modernization. More specifically, Altenstetter looks into how physicians and device companies connect to the government and bureaucracy, the relationships connecting Japanese patients to their medical system and governmental bureaucracy, and how the relationships between policymakers and the medical profession are changing. The issues addressed here are becoming increasingly relevant as numerous countries in Asia, Latin America, and Central and Eastern Europe are only now beginning to regulate medical technology, following the lead of the US and the European Union. Those interested in global medicine and Asian studies will find this book both informative and compelling.
| Author | : K. Atsumi |
| Publisher | : Springer Science & Business Media |
| Total Pages | : 256 |
| Release | : 2012-12-06 |
| Genre | : Technology & Engineering |
| ISBN | : 9400933614 |
The complete volume 12 of Medical Progress through Technology is devoted to the work of colleagues in Japan. Additionally, whole authority and responsibility both for the election of topics and for the reviewing procedure had been delegated to Guest Editors from Japan. What are the objectives of this special issue and why has Japan been elected to present itself in this way? International journals such as Medical Progress through Technology usually contain papers from authors all over the world. Such issues provide a rather comprehensive survey on different scientific projects but do not reflect the standard and extent of medical technology in a certain country. I think that issues like the present one give far better information on the actual state of research and development in a country than an irregular sequence of scientific reports. It is not intended that all future issues of Medical Progress through Technology will concern only national issues. The present issue is an exception. However, if the readers appreciate such an approach, then other national issues may be published. There are several reasons in favor of Japan preparing the first national issues. We all admire the history, tradition and culture of this country, but we are also impressed by the high standard of research, develop ment and technical realisation achieved in nearly all high technology fields. There is no doubt, that Japan is among the leading nations in the field of medical technology.
| Author | : National Research Council |
| Publisher | : National Academies Press |
| Total Pages | : 244 |
| Release | : 1992-02-01 |
| Genre | : Technology & Engineering |
| ISBN | : 0309047803 |
The perspectives of technologists, economists, and policymakers are brought together in this volume. It includes chapters dealing with approaches to assessment of technology leadership in the United States and Japan, an evaluation of future impacts of eroding U.S. technological preeminence, an analysis of the changing nature of technology-based global competition, and a discussion of policy options for the United States.
| Author | : Institute of Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 592 |
| Release | : 1985-02-01 |
| Genre | : Medical |
| ISBN | : 030903583X |
New drugs, new devices, improved surgical techniques, and innovative diagnostic procedures and equipment emerge rapidly. But development of these technologies has outpaced evaluation of their safety, efficacy, cost-effectiveness, and ethical and social consequences. This volume, which is "strongly recommended" by The New England Journal of Medicine "to all those interested in the future of the practice of medicine," examines how new discoveries can be translated into better care, and how the current system's inefficiencies prevent effective health care delivery. In addition, the book offers detailed profiles of 20 organizations currently involved in medical technology assessment, and proposes ways to organize U.S. efforts and create a coordinated national system for evaluating new medical treatments and technology.
| Author | : United States. Congress. House. Committee on Science, Space, and Technology. Subcommittee on Technology, Environment, and Aviation |
| Publisher | : |
| Total Pages | : 120 |
| Release | : 1993 |
| Genre | : Medical |
| ISBN | : |
| Author | : Laura Sampietro-Colom |
| Publisher | : Springer |
| Total Pages | : 384 |
| Release | : 2017-01-23 |
| Genre | : Medical |
| ISBN | : 3319392050 |
A timely work describing how localized hospital-based health technology assessment (HB-HTA) complements general, ‘arms-length’ HTA agency efforts, and what has been the collective global impact of HB-HTA across the globe. While HB-HTA has gained significant momentum over the past few years, expertise in the field, and information on the operation and organization of HB-HTA, has been scattered. This book serves to bring this information together to inform those who are currently working in the field of HTA at the hospital, regional, national or global level. In addition, this book is intended for decision-makers and policy-makers with a stake in determining the uptake and decommissioning of new and established technologies in the hospital setting. HTA has traditionally been performed at the National/Regional level by HTA Agencies, typically linked to governments. Yet hospitals are the main entry door for most health technologies (HTs). Hospital decision-makers must undertake multiple high stakes investment and disinvestment decisions annually for innovative HTs, usually without adequate information. Despite the existence of arms-length HTA Agencies, inadequate information is available to hospital decision-makers either because relevant HTA reports are not yet released at the time of entry of new technologies to the field, or because even when the report exists, the information contained is insufficient to clarify the contextualized informational needs of hospital decision makers. Therefore, there has recently been a rising trend toward hospital-based HTA units and programs. These units/programs complement the work of National/Regional HTA Agencies by providing the key and relevant evidence needed by hospital decision makers in their specific hospital context, and within required decision-making timelines. The emergence of HB-HTA is creating a comprehensive HTA ecosystem across health care levels, which creates better bridges for knowledge translation through relevance and timeliness.
| Author | : Christa Altenstetter |
| Publisher | : Routledge |
| Total Pages | : 219 |
| Release | : 2017-10-06 |
| Genre | : |
| ISBN | : 9781138512047 |
Cover -- Half Title -- Title Page -- Copyright Page -- Table of Contents -- List of Tables -- Acknowledgments -- Abbreviations -- 1 Introduction -- 2 Knowledge, Analyses, and Experiences -- 3 Medical Technology Regulation -- 4 The Pharmaceutical Affairs Law (PAL) -- 5 Responses to Global Pressures -- 6 Organizational Reform and Government Responsibilities -- 7 Advisory Committees, Science, and Reimbursement -- 8 Initiatives, Operations, and Processes -- 9 Realities of Clinical Medicine -- Summary and Concluding Comments -- Bibliography -- Index
| Author | : Naoki Ikegami |
| Publisher | : University of Michigan Press |
| Total Pages | : 320 |
| Release | : 2010-05-06 |
| Genre | : Medical |
| ISBN | : 0472024132 |
The Japanese health care system provides universal coverage to a healthy but aging population. Its costs are among the lowest in the world and have remained nearly constant as a share of the economy for more than a decade. Americans concerned about runaway medical spending need to know about the successes that Japan has experienced and the problems the country has encountered in its effort to control costs while maintaining quality of care. Offered here is an analysis of the key issues of cost-containment by specialists followed by reactions from some of America's best-known experts on health care delivery and finance. Topics include the macro-and microeconomics of health care, technology and costs, institutions and costs, attitudinal and behavioral aspects, and the politics of health care. This collection provides an authoritative study of successful cost-containment in the Japanese health care system---a chronicle of success that is neither a statistical illusion nor a result of sociocultural factors. Detailed here is information on the key mechanism of cost constraint: a fee schedule that covers virtually all medical services and rewards inexpensive services while making expensive services unprofitable. This system has resulted in the provision of quality health care to the entire population at roughly half the cost of American health care. Is it a single-payer system? Would the United States have to introduce a dramatically altered health care structure to benefit from the Japanese experience? No. Japan relies mainly on fee-for-service medicine financed by multiple insurers---a system familiar to Americans and one from which many lessons may be learned. Based on conferences held in Washington, D.C., and Izu, Japan, this volume collects original chapters on the overall cost structure, how the negotiated mandatory fee schedule works, specific mechanisms for cost control, the politics of health care financing, and the impact of cost cutting on quality, among other topics. These pathbreaking studies will be a significant resource for policymakers and scholars interested in comparative health care systems as well as those interested in health care reform in the United States.
